SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-023421
Filing Date
2021-06-11
Accepted
2021-06-11 21:02:15
Documents
1
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3841
  Complete submission text file 0000899243-21-023421.txt   5209
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Issuer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 55 FRUIT STREET YAWKEY 9E BOSTON MA 02114
Business Address
Flaherty Keith T. (Reporting) CIK: 0001579310 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35347 | Film No.: 211013005